Table of Contents
Print

What are the latest findings on ADHD in children born before 32 weeks? 

Early infant birth or Preterm and ADHD are closely linked in some research, as babies born prematurely are at a higher risk of developing ADHD later in life. Recent research has provided new insights into the long-term effects of premature birth on infant development. Several studies suggest that preterm birth, especially before 32 weeks, greatly increases the risk of ADHD and other neurodevelopmental disorders. 

Understanding the latest findings on preterm and ADHD helps inform early interventions that can reduce the severity of ADHD symptoms and improve the long-term outcomes for these vulnerable children. 

Key Findings on ADHD in Children Born Before 32 Weeks 

Here’s a breakdown of the latest findings on preterm and ADHD in children born before 32 weeks

Increased risk of ADHD symptoms

Recent studies have confirmed that children born before 32 weeks are at a significantly higher risk of developing ADHD. This is due to the fact that the brain structures responsible for these functions are still developing during the third trimester and may not fully mature in extremely premature infants. 

Brain development delays

Infant development is often slower in premature infants as compared to full-term infants. Studies using advanced neuroimaging techniques have shown that these children tend to have reduced volumes in key brain areas responsible for attention and executive function.  

Long-term behavioural outcomes

Research tracking children born before 32 weeks into adolescence and adulthood has found that ADHD symptoms often persist over time. These children are more likely to struggle with academic performance, social relationships, and emotional regulation. Early identification of ADHD and appropriate interventions can help manage these long-term outcomes and improve quality of life. 

Genetic factors

Some studies suggest that genetic factors may also contribute to the development of ADHD in preterm infants. In children born before 32 weeks, a combination of premature birth and a family history of ADHD may increase the risk of developing the disorder. Twin studies and genetic research are beginning to shed light on how genes and the prenatal environment interact to affect preterm ADHD

Neonatal care

Improved neonatal care has led to better survival rates for infants born before 32 weeks, but the increased survival rate also highlights the need for early developmental support. Early intervention programs that focus on infant development, including cognitive and behavioural therapies, have been shown to reduce the severity of ADHD symptoms and improve outcomes for preterm infants. 

Environmental influences

The environmental factors that preterm infants are exposed to after birth, such as their home environment, prenatal stress exposure, and early childhood experiences can also influence the likelihood of developing ADHD. Studies have found that stable home environments, parental support, and early educational interventions play a crucial role in mitigating ADHD symptoms in children born before 32 weeks

The latest findings on preterm ADHD emphasise the importance of early diagnosis and intervention for children born before 32 weeks. By understanding the risks associated with prematurity and the potential for ADHD, healthcare providers and parents can work together to improve the developmental outcomes of these children. 

Visit providers like ADHD Certify for personal consultations and tailored guidance. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to premature birth or low birth weight

Avery Lombardi, MSc, author for my patient advice - mypatientadvice.co.uk

Avery Lombardi, MSc

Author

Avery Lombardi is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Psychology. She has professional experience in psychological assessment, evidence-based therapy, and research, working with both child and adult populations. Avery has provided clinical services in hospital, educational, and community settings, delivering interventions such as CBT, DBT, and tailored treatment plans for conditions including anxiety, depression, and developmental disorders. She has also contributed to research on self-stigma, self-esteem, and medication adherence in psychotic patients, and has created educational content on ADHD, treatment options, and daily coping strategies.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.